Landec Corporation Sets Second Quarter Fiscal Year 2020 Earnings Conference Call for January 3, 2020 at 8 a.m. PT and Earning...
13 December 2019 - 1:15AM
Landec Corporation (Nasdaq: LNDC), a diversified health and
wellness company with two operating businesses, Curation Foods,
Inc. and Lifecore Biomedical, Inc., will hold a conference call on
Friday January 3, 2020 at 8 a.m. Pacific time to discuss its
results for the second quarter fiscal year 2020. Financial results
will be reported for the 2020 fiscal second quarter ended November
24, 2019 after market close on January 2, 2020.
Landec's President and CEO, Dr. Albert D. Bolles, will host the
Conference Call with Gregory S. Skinner, Executive Vice President
Finance and CFO. A question and answer period will follow the
presentation.
Date: Friday January 3, 2020Time: 8 a.m. Pacific time (11 a.m.
Eastern time)Toll Free Participant Dial-in Number:
1-877-407-3982U.S. and International Toll Number:
1-201-493-6780Conference ID: 13697215Webcast:
http://ir.Landec.com/events.cfmThe webcast will be available for 30
days through February 2, 2020.
A replay of the teleconference will be available for one week
until midnight Eastern Time on Friday January 10, 2020.
Toll free replay dial in: 1-844-512-2921International replay:
1-412-317-6671Replay passcode: 13697215
About Landec Corporation Landec Corporation
(Nasdaq: LNDC) is a leading innovator of diversified health and
wellness solutions with two operating businesses: Curation Foods,
Inc. and Lifecore Biomedical, Inc. Curation Foods is focused on
innovating and distributing plant-based foods with 100% clean
ingredients to retail, club and foodservice channels throughout
North America. Curation Foods is able to maximize product freshness
through its geographically dispersed family of growers,
refrigerated supply chain and patented BreatheWay® packaging
technology. Curation Foods brands include Eat Smart® fresh
packaged vegetables and salads, O Olive Oil &
Vinegar® premium artisan products, and Yucatan® and Cabo
Fresh® avocado products. Lifecore Biomedical is a fully integrated
contract development and manufacturing organization (CDMO) that
offers highly differentiated capabilities in the development, fill
and finish of difficult to manufacture pharmaceutical products in
syringes and vials. As a leading manufacturer of premium,
injectable grade Hyaluronic Acid, Lifecore brings 35 years of
expertise as a partner for global and emerging biopharmaceutical
and biotechnology companies across multiple therapeutic categories
to bring their innovations to market. For more information about
the company, visit Landec’s website at www.landec.com.
Contact Information: |
|
|
|
At the
Company: |
Investor
Relations: |
Gregory S. Skinner |
Jeff Sonnek |
Executive Vice President Finance
and CFO |
(646) 277-1263 |
(650) 261-3677 |
Jeff.Sonnek@ICRINC.com |
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Apr 2024 to May 2024
Landec (NASDAQ:LNDC)
Historical Stock Chart
From May 2023 to May 2024